Jonathan McNeill, Chief Business Officer at Dyne Therapeutics, Inc. (DYN), sold 4,868 shares at $25.85 ($126K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($126k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 2,434 | $63K | 50.0% |
| 2 | $25.85 | 2,434 | $63K | 50.0% |
| Total | $25.85 avg | 4,868 | $126K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |